Aurélie Louvet Natasha Honoré Anne-France Dekairelle Cédric Van Marcke Jean-Charles Goeminne
10.3389/fonc.2023.1143775
Front Oncol
2023 Jul 3;13:1143775.
egfr exon 20 multimodal non-small cell lung cancer osimertinib stereotaxic radiotherapy tyrosine kinase inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/37465107/
Case Reports
PMC10350683
37465107
Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report
2023